Better Therapeutics, Inc. (BTTX) Income Tax Expense (Benefit) USD 2020 - 2022

Historical data

Taxonomy & unit: us-gaap: USD
Description: Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary: Better Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2020 to 2022.
Better Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2023 was $3 K, unchanged year-over-year.
Better Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2022 was $7 K.
Better Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was -$153 K, a 200% decline from 2020.

Income Tax Expense (Benefit), Annual (USD)

Income Tax Expense (Benefit), YoY Annual Growth (%)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
2022	$7 K	+$160 K		Jan 1, 2022	Dec 31, 2022	10-K	2023-03-30
2021	-$153 K	-$306 K	-200%	Jan 1, 2021	Dec 31, 2021	10-K	2023-03-30
2020	$153 K			Jan 1, 2020	Dec 31, 2020	10-K	2022-03-28

* An asterisk sign (*) next to the value indicates that the value is likely invalid.